| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/22/2004 | CA2499586A1 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 04/22/2004 | CA2498658A1 Dibenzoxazepine |
| 04/22/2004 | CA2465860A1 Methods and compositions for therapeutic use of rna interference |
| 04/21/2004 | EP1411128A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 04/21/2004 | EP1411049A1 Estrogen Agonists/Antagonists |
| 04/21/2004 | EP1410822A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 04/21/2004 | EP1410798A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 04/21/2004 | EP1410797A1 Solid oral dosage forms comprising valsartan |
| 04/21/2004 | EP1410796A2 New therapeutic uses for potassium channel openers |
| 04/21/2004 | EP1410792A1 Microparticles |
| 04/21/2004 | EP1410038A2 Assays for identifying modulators of rhomboid polypeptides |
| 04/21/2004 | EP1410034A2 Methods and compositions for the treatment and prevention of smooth muscle cell proliferation |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409690A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409670A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409510A2 Biological pacemaker |
| 04/21/2004 | EP1409509A2 Antisense modulation of c-reactive protein expression |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409488A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |
| 04/21/2004 | EP1409483A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 04/21/2004 | EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/21/2004 | EP1409449A1 Alpha-ketoglutarates of active ingredients and compositions containing same |
| 04/21/2004 | EP1409446A1 Method for the nitration of phenolic compounds |
| 04/21/2004 | EP1409080A1 Medicament inhibiting sodium/calcium exchange system |
| 04/21/2004 | EP1409077A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 04/21/2004 | EP1409008A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP1409006A2 Methods of treating diabetes mellitus |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1409000A4 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1409000A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408992A2 Pharmaceutical composition for treating hypercholesterolaemia |
| 04/21/2004 | EP1408989A2 Method and material for treating immune diseases |
| 04/21/2004 | EP1408987A2 Tetracycline compounds having target therapeutic activities |
| 04/21/2004 | EP1408977A1 A combination therapy for the treatment of heart failure |
| 04/21/2004 | EP1408962A1 Substituted isoindoles and the use thereof |
| 04/21/2004 | EP1408959A1 Use of galiella lactone |
| 04/21/2004 | EP1408958A1 Benzofuranes and their use in the treatment of atrial fibrillation |
| 04/21/2004 | EP1408952A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 04/21/2004 | EP1408950A2 Methods of treating cytokine mediated diseases |
| 04/21/2004 | EP1408949A2 Glycine betaine and its use as anti-hemorrhagic agent |
| 04/21/2004 | EP1408947A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 04/21/2004 | EP1408943A2 Pharmaceutical formulation containing an ltb4 antagonist |
| 04/21/2004 | EP1408931A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
| 04/21/2004 | EP1408775A2 Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain |
| 04/21/2004 | EP1287355B1 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1121099B1 Pharmaceutical composition with gastric residence and controlled release |
| 04/21/2004 | EP1113790B1 Use of a cinnamic acid derivatives for the manufacture of a medicament for preventing or treating elevated blood lipid level-related diseases |
| 04/21/2004 | EP1109814B1 5-heterocyclyl pyrazolo 4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | EP1007030B1 Solid pharmaceutical composition containing benzofurane derivatives |
| 04/21/2004 | EP0964860B1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 04/21/2004 | EP0939654B1 Use of no syntase inhibitors with scavengers of oxygen reactive forms for the treatment of ischemia |
| 04/21/2004 | EP0856007B1 Cyclopeptide derivatives |
| 04/21/2004 | EP0815218B1 Human vegf-specific antisense oligonucleotides |
| 04/21/2004 | EP0683781B1 Novel inhibitors of adenosine monophosphate deaminase |
| 04/21/2004 | CN1491227A Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine A3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491220A Lactone compound as novel photoinitiators |
| 04/21/2004 | CN1491213A Novel benzoylguanidine salt |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491112A Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 04/21/2004 | CN1491110A Medical composition for treatment of chronic cardiac failure |
| 04/21/2004 | CN1491105A Novel modified released formulation |
| 04/21/2004 | CN1491104A Novel modified release formulation |
| 04/21/2004 | CN1490321A Effective parts of fructus sophorae flavone production and use thereof |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1490046A Chinese medicine for cardiac and encephalic ischemia |
| 04/21/2004 | CN1490038A Products as food or medicine against thrombus and cardiac and encephalic blood vessel diseases and reducing fat and their productions |
| 04/21/2004 | CN1490035A Chinese medicinal composition for treating piles and preparing method thereof |
| 04/21/2004 | CN1490028A Chinese medicinal preparations for cardiac and encephalic blood vessel diseases and productions thereof |
| 04/21/2004 | CN1490026A Bear gall lozenge and preparing method thereof |
| 04/21/2004 | CN1490025A Bear gall granular formulation and preparing method thereof |
| 04/21/2004 | CN1490024A Preparations of composition and fumigant for prosopalgia |
| 04/21/2004 | CN1490019A Health cosmetic composition |